Rajinder Suri | Chief Executive Officer
Developing Countries Vaccine Manufacturers Network

Rajinder Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers Network

Rajinder as CEO-DCVMN International is responsible for providing leadership, shaping strategic vision, governance and overall operational excellence of DCVMN.  Rajinder is serving as committee delegate on GAVI-PPC and has been a member of GAVI’s Vaccine Investment Strategy (VIS) Steering Committee 2024, is a permanent member of CEPI’s Joint Coordination Group (JCG), 2023-24 and a member of PAVMs Talent Development WS. Rajinder is on the Strategic Advisory Board of the Regional Vaccine Manufacturing Collaborative (RVMC). He is on the Governing Board of Life Sciences Skill Development Council (LSSSDC)India. Rajinder has contributed as a member of several advisory expert groups including COVAX Manufacturing & Supply Chain Task Force Leadership Team, G-20 Health Working Group and Market Design and Demand Intelligence pillar of PAVM.

Appearances:



Main Congress Day 2 - 23rd April @ 12:10

Panel: Strengthening the market and regulatory access of vaccines in Africa

  • How do we increase local vaccine manufacturing capacity and bolster regulatory systems within African nations?
  • The power of fostering regional collaboration on procurement and market dynamics
  • Building capacity for R&D and implementing and strengthening African vaccine manufacturers
  • The need for targeted initiatives to address vaccine hesitancy

Main Congress Day 2 - 23rd April @ 17:10

COVID & beyond panel: Which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facilities and incorporate novel platforms?

last published: 22/Apr/25 22:05 GMT

back to speakers